Atlas Trials

Reduced Anticoagulation Targets in ECLS (RATE)

Clinical trial NCT04536272 · COMPLETED

Trial details

NCT number
NCT04536272
Sponsor
University Medical Center Groningen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Heart FailureRespiratory FailureExtracorporeal Membrane OxygenationBleedingThrombosis
Start date
2020-10-01
Primary completion
2025-03-07
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.